摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,6-dimethoxybenzohydroxamic acid | 51410-99-2

中文名称
——
中文别名
——
英文名称
2,6-dimethoxybenzohydroxamic acid
英文别名
N-hydroxy-2,6-dimethoxybenzamide;2.6-Dimethoxybenzohydroxamsaeure;2,6-Dimethoxybenzenecarbohydroxamic acid
2,6-dimethoxybenzohydroxamic acid化学式
CAS
51410-99-2
化学式
C9H11NO4
mdl
MFCD09928732
分子量
197.191
InChiKey
UCSCCSDEGMOIQL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    201.2-201.5 °C(Solv: ethyl acetate (141-78-6))
  • 密度:
    1.241±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.222
  • 拓扑面积:
    67.8
  • 氢给体数:
    2
  • 氢受体数:
    4

SDS

SDS:6cc1ad43e4d711fbb283f93a6a0c6276
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,6-dimethoxybenzohydroxamic acid乙酸酐potassium carbonate盐酸 作用下, 以 二甲基亚砜 为溶剂, 反应 0.17h, 以93%的产率得到2,6-二甲氧基苯胺
    参考文献:
    名称:
    在温和条件下由催化量的活化剂诱导的自传播洛森重排
    摘要:
    已经开发了在中等至高极性有机溶剂中由催化量的活化剂引起的温和的自蔓延的洛森重排。在催化量(0.01当量)的乙酸酐和等摩尔量的碱(如干燥的碳酸钾)的存在下,芳族和脂族异羟肟酸的重排可以高收率得到相应的胺。传统Lossen重排的替代方法为从游离异羟肟酸合成胺提供了一种简单温和的方法。
    DOI:
    10.1016/j.tetlet.2014.12.084
  • 作为产物:
    描述:
    2,6-二甲氧基苯甲酸甲酯盐酸羟胺 、 potassium hydroxide 作用下, 以 甲醇 为溶剂, 反应 12.0h, 以50%的产率得到2,6-dimethoxybenzohydroxamic acid
    参考文献:
    名称:
    碱介导的异羟肟酸的自我繁殖洛森重排,可有效而轻松地合成芳族和脂族伯胺†
    摘要:
    通过碱介导的重排将多种芳族和脂族异羟肟酸转化为相应的伯胺。这种重新排列可以少于1个当量进行。无需外部试剂的热条件下,在极性溶剂中分离K 2 CO 3。该重排具有几个特征,包括不需要用于促进重排的外部活化剂,少于一当量的碱足以进行该反应,以及其中仅产生二氧化碳作为副产物的清洁反应。提出了通过异氰酸酯中间体的自增长机理,并通过实验支持了基本的反应步骤,即链增长反应。
    DOI:
    10.1039/c6ob01178k
点击查看最新优质反应信息

文献信息

  • Base-mediated rearrangement of free aromatic hydroxamic acids (ArCO–NHOH) to anilines
    作者:Yujiro Hoshino、Moriaki Okuno、Eri Kawamura、Kiyoshi Honda、Seiichi Inoue
    DOI:10.1039/b822806j
    日期:——
    Without using activating agents, a variety of free aromatic hydroxamic acids could be rearranged to aromatic amines in the presence of base alone.
    在不使用活化剂的情况下,可以在仅存在碱的情况下将多种游离的芳族异羟肟酸重排为芳族胺。
  • Self-propagated Lossen rearrangement induced by a catalytic amount of activating agents under mild conditions
    作者:Yujiro Hoshino、Yuki Shimbo、Naoya Ohtsuka、Kiyoshi Honda
    DOI:10.1016/j.tetlet.2014.12.084
    日期:2015.1
    self-propagated Lossen rearrangement induced by a catalytic amount of activating agents in medium to high polar organic solvents has been developed. The rearrangement of aromatic and aliphatic hydroxamic acids in the presence of a catalytic amount (0.01 equiv) of acetic anhydride and an equimolar amount of base such as well-dried potassium carbonate afforded the corresponding amines in high yields.
    已经开发了在中等至高极性有机溶剂中由催化量的活化剂引起的温和的自蔓延的洛森重排。在催化量(0.01当量)的乙酸酐和等摩尔量的碱(如干燥的碳酸钾)的存在下,芳族和脂族异羟肟酸的重排可以高收率得到相应的胺。传统Lossen重排的替代方法为从游离异羟肟酸合成胺提供了一种简单温和的方法。
  • Benzohydroxamic acids as potent and selective anti-HCV agents
    作者:Maxim V. Kozlov、Alla A. Kleymenova、Lyudmila I. Romanova、Konstantin A. Konduktorov、Olga A. Smirnova、Vladimir S. Prasolov、Sergey N. Kochetkov
    DOI:10.1016/j.bmcl.2013.08.081
    日期:2013.11
    A diverse collection of 40 derivatives of benzohydroxamic acid (BHAs) of various structural groups were synthesized and tested against hepatitis C virus (HCV) in full-genome replicon assay. Some of these compounds demonstrated an exceptional activity, suppressing viral replication at sub-micromolar concentrations. The compounds were inactive against key viral enzymes NS3, and NS5B in vitro assays, suggesting host cell inhibition target(s). The testing results were consistent with metal coordination by the BHAs hydroxamic group in complex with a target(s). Remarkably, this class of compounds did not suppress poliomyelitis virus (PV) propagation in RD cells indicating a specific antiviral activity of BHAs against HCV. (C) 2013 Elsevier Ltd. All rights reserved.
  • ——
    作者:Tyrone Woodard、Manik L. Debnath、Rupendra Simlot、Robert A. Izydore、Dwayne L. Daniels、Oi T. Wong、Hamby ElSourady、Iris H. Hall
    DOI:10.1023/a:1016226317975
    日期:——
    A series of 2-benzoyl-4,4-dialkyl-3,5-isoxazolidinediones proved to have potent hypolipidemic activity, lowering both serum cholesterol and triglyceride levels at 10 or 20 mg/kg/day, IP and orally in rodents. 2-(3,4,5-Trimethoxybenzoyl)-4,4-diethyl-3,5-isoxazolidinedione (4) afforded the best hypolipidemic activity lowering normolipidemic CF1 mouse serum cholesterol levels 49% and serum triglyceride levels 34% at 20 mg/kg/day, IP. Compound 4 was selected as a typical derivative of the chemical class for further detailed studies. Serum cholesterol levels in normolipidemic Sprague Dawley male rats were reduced 45% after 8 weeks at 10 and 20 mg/kg/day of compound, orally. Serum triglyceride levels were reduced 38-49% at 10 and 20 mg/kg/day, orally. In vitro liver enzyme activities studies in normolipidemic CF1 mice showed the compound inhibited mitochondrial citrate exchange, acetyl CoA synthetase, HMG CoA reductase, acyl CoA cholesterol acyl transferase, acetyl CoA carboxylase, sn-glycerol-3-phosphate acyl transferase, phosphatidylate phosphohydrolase and heparin-induced lipoprotein lipase activities with increases in the activities of cholesterol ester hydrolase and ATP-dependent citrate lyase. Similar enzyme activities were inhibited in vivo except HMG CoA reductase activity was not inhibited in rat liver or small intestinal mucosa after 8 weeks drug administration. Cholesterol levels were reduced in tissues after 8 weeks administration of compound 4 in normolipidemic rats. Bile cholesterol and triglyceride levels were elevated after two weeks administration to rats at 20 mg/kg/day. Serum lipoprotein levels in normolipidemic and hyperlipidemic rats showed the cholesterol levels in VLDL and LDL fractions after 4, 6 and 8 weeks at 10 and 20 mg/kg/day were reduced whereas HDL-cholesterol levels were significantly elevated. Studies demonstrated that H-3-cholesterol and C-14-palmitic acid incorporation into lipids of the lipoprotein fraction was reduced by the drug but P-32-incorporation was generally elevated. The agent demonstrated no observable toxicity in rats after 8 weeks administration, orally. The acute toxicity study in normolipidemic mice at 20, 40 and 100 mg/kg/day, IP, demonstrated no observable harmful effects of the drug.
  • KONAJE A. C.; HOSANGADI B. D., INDIAN J. CHEM., 1979, B17, NO 3, 275-276
    作者:KONAJE A. C.、 HOSANGADI B. D.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐